Oragenics Inc financial data

Symbol
OGEN on NYSE
Location
1990 Main Street, Suite 750, Sarasota, FL
State of incorporation
FL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 514 % -57.9%
Return On Equity -573 % -447%
Return On Assets -409 % -346%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.58M shares +120%
Common Stock, Shares, Outstanding 5.58M shares +176%
Entity Public Float 6.7M USD -83.9%
Common Stock, Value, Issued 5.58K USD +176%
Weighted Average Number of Shares Outstanding, Basic 4.53M shares +124%
Weighted Average Number of Shares Outstanding, Diluted 4.53M shares +124%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 37.7K USD -71.4%
Research and Development Expense 13.4M USD +70.1%
General and Administrative Expense 6.28M USD +40.6%
Operating Income (Loss) -19.7M USD -60.9%
Nonoperating Income (Expense) 141K USD -35.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -19.5M USD -62.6%
Net Income (Loss) Attributable to Parent -19.5M USD -62.6%
Earnings Per Share, Basic -7.47 USD/shares -26.8%
Earnings Per Share, Diluted -7.47 USD/shares +66.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.35M USD -79.2%
Assets, Current 1.62M USD -80%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 9.81K USD -97.2%
Assets 2.71M USD -68%
Accrued Liabilities, Current 181K USD -45.9%
Liabilities, Current 1.8M USD +12.6%
Operating Lease, Liability, Noncurrent 65.8K USD -69.7%
Liabilities 1.38M USD
Retained Earnings (Accumulated Deficit) -211M USD -10.2%
Stockholders' Equity Attributable to Parent 1.33M USD -81.7%
Liabilities and Equity 2.71M USD -68%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.06M USD -45.3%
Net Cash Provided by (Used in) Financing Activities 1.65M USD
Net Cash Provided by (Used in) Investing Activities -75K USD
Common Stock, Shares Authorized 350M shares +8300%
Common Stock, Shares, Issued 5.58M shares +176%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.41M USD +37.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 7.09K USD +112%
Deferred Tax Assets, Valuation Allowance 47M USD +14.1%
Deferred Tax Assets, Gross 47M USD +14.1%
Operating Lease, Liability 9.81K USD -97.3%
Payments to Acquire Property, Plant, and Equipment 87K USD
Lessee, Operating Lease, Liability, to be Paid 9.89K USD -97.4%
Property, Plant and Equipment, Gross 1.48M USD
Operating Lease, Liability, Current 9.81K USD -95.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 157K USD +6.74%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.89K USD -95.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 381 USD -98.4%
Deferred Tax Assets, Operating Loss Carryforwards 39.8M USD +5.56%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 4.17M USD -13.8%
Operating Lease, Payments 59.3K USD +1.26%
Additional Paid in Capital 211M USD +6.89%
Share-based Payment Arrangement, Expense 58.2K USD -8.5%
Interest Expense 34.3K USD +126%